Möchten Sie immer auf dem neuesten Stand bleiben?

Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR

The Complaint alleges Jasper lacked proper manufacturing controls, risking trial integrity, overstating briquilimab’s prospects, and misleading investors.

JASPER, Ind., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Peak Toolworks, North America’s largest manufacturer and servicer of engineered diamond and carbide cutting tools, today announced the acquisition of...

LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

ATLANTA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Jasper...

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November...

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

MOUNTAIN VIEW, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ThoughtSpot, the Agentic Analytics Platform company, today announced a significant uptick in adoption driven by demand for trusted, Agentic...

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...

LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 18, 2025 deadline to file a lead plaintiff motion in the class action filed...